Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 55
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Probiotics for plants? Fighting insects by boosting corn immune systems

Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

Can we stop amphibian extinction by increasing immunity to the frog chytrid fungus?

As a result of the arrival of the chytrid fungus in Australia, corroboree frog populations declined so now...

Creating a Genetic Circuit Control Toolbox

Synthetic biology studies the design of genetic circuits to program cells to solve problems in areas like...

Backer Badge Funded